Entera Bio Ltd (ENTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $541.57M
Last updated: Nov 17, 2026 at 11:04 AM ET
Entera Bio Ltd (ENTX) Earnings: Report Dates and Results
Entera Bio (ENTX) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Entera Bio reported EPS of -$0.11, below the -$0.07 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ENTX has an expected report date of Mar 25, 2027.
Earnings History
Of the 33 quarters below that had an estimate, ENTX beat 20, missed 11 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 258.33% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.11 | -$0.07 | -$0.09 - -$0.05 | -57.14% | Miss | N/A | 5 | 0 up, 0 down | Nov 6, 2026 | N/A |
| Jun 30, 2026 | -$0.14 | -$0.08 | -$0.08 - -$0.08 | -75.00% | Miss | N/A | 1 | 1 up, 0 down | Aug 7, 2026 | N/A |
| Mar 31, 2026 | -$0.07 | -$0.08 | -$0.08 - -$0.08 | +12.50% | Beat | N/A | 1 | 1 up, 0 down | May 8, 2026 | N/A |
| Dec 31, 2025 | -$0.06 | -$0.11 | N/A | +45.45% | Beat | N/A | 1 | 1 up, 0 down | Mar 27, 2026 | N/A |
| Sep 30, 2025 | -$0.07 | -$0.09 | -$0.09 - -$0.09 | +22.22% | Beat | N/A | 1 | 1 up, 0 down | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$0.06 | -$0.11 | N/A | +45.45% | Beat | N/A | N/A | 0 up, 0 down | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$0.06 | -$0.07 | N/A | +14.29% | Beat | N/A | N/A | 0 up, 0 down | May 9, 2025 | $42000 |
| Dec 31, 2024 | -$0.06 | -$0.08 | N/A | +25.00% | Beat | N/A | N/A | 0 up, 0 down | Mar 28, 2025 | $82000 |
| Sep 30, 2024 | -$0.08 | -$0.05 | -$0.05 - -$0.05 | -60.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 8, 2024 | $42000 |
| Jun 30, 2024 | -$0.06 | -$0.06 | -$0.06 - -$0.06 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Aug 9, 2024 | $57000 |
| Mar 31, 2024 | -$0.05 | -$0.06 | -$0.06 - -$0.06 | +16.67% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2024 | N/A |
| Dec 31, 2023 | -$0.07 | -$0.08 | N/A | +12.50% | Beat | N/A | N/A | 0 up, 0 down | Mar 8, 2024 | $4.48M |
| Sep 30, 2023 | -$0.08 | -$0.09 | -$0.09 - -$0.09 | +11.11% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2023 | N/A |
| Jun 30, 2023 | -$0.08 | -$0.07 | -$0.07 - -$0.07 | -14.29% | Miss | N/A | 1 | 0 up, 0 down | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$0.08 | -$0.12 | -$0.12 - -$0.12 | +33.33% | Beat | N/A | 1 | 0 up, 0 down | May 5, 2023 | N/A |
| Dec 31, 2022 | -$0.10 | -$0.11 | -$0.12 - -$0.11 | +9.09% | Beat | N/A | 2 | 0 up, 0 down | Mar 27, 2023 | $14000 |
| Sep 30, 2022 | -$0.11 | -$0.13 | -$0.16 - -$0.11 | +15.38% | Beat | N/A | 2 | 0 up, 0 down | Nov 10, 2022 | $8000 |
| Jun 30, 2022 | -$0.11 | -$0.16 | -$0.24 - -$0.10 | +31.25% | Beat | N/A | 4 | 1 up, 0 down | Aug 11, 2022 | $44000 |
| Mar 31, 2022 | -$0.13 | -$0.18 | -$0.20 - -$0.16 | +27.78% | Beat | N/A | 3 | 0 up, 0 down | May 12, 2022 | $68000 |
| Dec 31, 2021 | -$0.21 | -$0.23 | -$0.46 - -$0.11 | +8.70% | Beat | N/A | 3 | N/A | Mar 8, 2022 | $165000 |
| Sep 30, 2021 | -$0.05 | -$0.11 | -$0.13 - -$0.10 | +54.55% | Beat | N/A | 2 | 1 up, 0 down | Nov 10, 2021 | $140000 |
| Jun 30, 2021 | -$0.21 | -$0.12 | -$0.14 - -$0.10 | -75.00% | Miss | N/A | 3 | N/A | Aug 16, 2021 | $109000 |
| Mar 31, 2021 | -$0.43 | -$0.12 | -$0.12 - -$0.12 | -258.33% | Miss | -368.7% | 1 | N/A | May 20, 2021 | $157000 |
| Dec 31, 2020 | -$0.13 | -$0.14 | -$0.14 - -$0.14 | +7.14% | Beat | N/A | 1 | N/A | Mar 18, 2021 | $221000 |
| Sep 30, 2020 | -$0.09 | -$0.20 | -$0.20 - -$0.20 | +55.00% | Beat | N/A | 1 | N/A | Nov 19, 2020 | $50000 |
| Jun 30, 2020 | -$0.17 | -$0.12 | N/A | -41.67% | Miss | N/A | N/A | N/A | Aug 20, 2020 | $52000 |
| Mar 31, 2020 | $0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 21, 2020 | $42000 |
| Dec 31, 2019 | -$0.26 | -$0.19 | N/A | -36.84% | Miss | N/A | N/A | N/A | Mar 26, 2020 | $102000 |
| Sep 30, 2019 | -$0.25 | -$0.15 | -$0.15 - -$0.15 | -66.67% | Miss | N/A | 1 | N/A | Nov 21, 2019 | $60000 |
| Jun 30, 2019 | -$0.12 | -$0.28 | -$0.28 - -$0.28 | +57.14% | Beat | N/A | 1 | N/A | Aug 20, 2019 | $74000 |
| Mar 31, 2019 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 27, 2019 | $74000 |
| Dec 31, 2018 | -$0.17 | -$0.35 | -$0.35 - -$0.35 | +51.43% | Beat | N/A | 1 | N/A | Jan 22, 2019 | $500000 |
| Sep 30, 2018 | -$0.45 | -$0.28 | N/A | -60.71% | Miss | N/A | N/A | N/A | Sep 30, 2018 | N/A |
| Jun 30, 2018 | -$0.16 | -$0.09 | N/A | -77.78% | Miss | N/A | N/A | N/A | Aug 20, 2018 | N/A |
| Mar 31, 2018 | -$0.08 | -$0.08 | -$0.08 - -$0.08 | 0.00% | In line | N/A | 1 | N/A | Jun 29, 2018 | N/A |
| Dec 31, 2017 | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 | N/A |
| Sep 30, 2017 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2017 | N/A |
| Mar 31, 2017 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2017 | N/A |
| Dec 31, 2016 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2017 | N/A |
| Sep 30, 2016 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 4, 2016 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.25, after -$0.25 the year before. It was -$0.22 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.25 | N/A |
| Dec 31, 2024 | -$0.25 | N/A |
| Dec 31, 2023 | -$0.31 | N/A |
| Dec 31, 2022 | -$0.45 | N/A |
| Dec 31, 2021 | -$0.90 | N/A |
| Dec 31, 2020 | -$0.23 | N/A |
| Dec 31, 2019 | -$0.89 | N/A |
| Dec 31, 2018 | -$0.86 | N/A |
| Dec 31, 2017 | -$0.63 | N/A |
| Dec 31, 2016 | -$0.22 | N/A |
Frequently Asked Questions About ENTX
When is Entera Bio's next earnings date?
Entera Bio's next earnings report is expected for Mar 25, 2027.
Did ENTX beat earnings estimates last quarter?
No. Entera Bio reported EPS of -$0.11 for the quarter ended Sep 30, 2026, below the -$0.07 estimate by 57.14%.
What EPS do analysts expect from ENTX next quarter?
The consensus EPS estimate for Entera Bio for the quarter ending Dec 31, 2026 is -$0.14 from 7 analysts, with estimates from -$0.21 to -$0.05.
How often does ENTX beat earnings estimates?
Entera Bio beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +4.10%.
ENTX pages: Overview, Earnings, Forecast, Financials, Competitors